NG12 Cancer Recognition – Urology (HP222)

NG12 Cancer Recognition – Urology (HP222)

Purpose:
The HP222 NG12 Cancer Recognition – Urology protocol alert is an innovative tool designed for use within EMIS. This protocol is paired with our existing HP197 NG12 Cancer Recognition - PSA Radar and serves as an optional alert system aimed at aiding clinicians in the early recognition and appropriate referral of patients at risk of urological cancers. 

What does it actually do?

The primary objective of this protocol is to identify patients who may be at risk of an undiagnosed urological cancer according to signs and symptoms noted in NICE NG12 guidance, for example,  

  1. Those who have undergone multiple treatments for urinary tract infections (UTIs) without in-depth investigation.  
  2. Those with coded urinary dipstick abnormalities. 
  3. Those with raised white cell counts in association with urinary dipstick abnormalities. 
  4. Those with coded urological symptoms. 
It focuses on leveraging accurate coding of symptoms, signs, and results from the records, including prescribing data and urine dipstick analyses to facilitate early cancer detection. 

What does it look like?

The alert itself appears like this, detailing the type of issue noted:


When users hover over the PCIT HP222 NG12 alert, they are provided with more detail about the risk factors identified for urological cancer:

System Dependencies:

The effectiveness of this protocol is contingent on accurate and complete data entry. Inaccurate or incomplete coding may lead to missed alerts.

System Trigger

Document triggers here
System Trigger: Load a patient
Run mode: Always run 
Enable trigger for: All clinical prescribers

Fitting your practice

Users need to be aware of the NG12 guidance around suspected urological cancers.  They also need to be aware that this alert will flag patients who have high risk to them.

How to get it

This protocol is an optional Handy Protocol.  If you would like this installing in your site please submit a ticket to request this.

Support Information

Development Log

VERSION NUMBER

Published 4/3/24
Release notes: Initial release

Communications Log

Exciting News: Release of HP222 NG12 Cancer Recognition – Urology! 

 

We're thrilled to announce the launch of our latest protocol alert, HP222 NG12 Cancer Recognition – Urology, designed to revolutionize cancer detection in primary healthcare settings. 🩺✨

 

🎯 Objective:

Identify patients at risk of urological cancers based on specific signs and symptoms noted in NICE NG12 guidance.

 

🛠️ Implementation:

Integrated into the EMIS system, HP222 leverages accurate coding of symptoms, signs, and results to facilitate early cancer detection.

 

🔍 Key Features:

Identification of high-risk patients based on UTI treatments and urine dipstick abnormalities.

Automated alert system prioritizing patients lacking recent urological evaluations.

Streamlined referral process for comprehensive patient evaluation.


💡 Benefits:

Enhanced early detection of urological cancers.

Improved patient outcomes through timely referrals and evaluations.

Efficient utilization of EMIS for cancer detection and patient care.


⚡ Conclusion:

HP222 NG12 Cancer Recognition – Urology represents a significant advancement in cancer detection within primary healthcare. Its focus on detailed symptom recording and automated alert generation makes it a crucial tool for clinicians in the early identification of urological cancers.


This is an optional handy protocol.  If you would like this installing in your site please submit a ticket to request this. 

    • Related Articles

    • NG12 Cancer Recognition - PSA Radar (HP197)

      NG12 Cancer Recognition - PSA Radar (HP197) Overview/Purpose The Prostate Specific Antigen (PSA) radar is designed to improve the detection of prostate cancer and to spot progression of established prostate cancer. The alert informs a user when ...

    • Cancer Resources

      Screening Resources Searches These are found in the PCIT folder 028: National Screening Programmes Alerts The PCIT National Screening Programmes Alert highlights any patients who are overdue for cervical, breast, bowel or abdominal aortic aneurysm ...

    • Potential Cancer Alert (HP239)

      Purpose: This protocol will: Searches for common symptoms known to lead to cancer. Flags repeated occurrences over 12 months. Prompts clinicians to "think cancer" for timely diagnosis. What does it actually do? On saving the patient record, the ...

    • Lung Cancer Radar (HP190)

      Purpose: This protocol will highlight to users where a patient may be at risk of lung cancer. What does it actually do? This protocol alert highlights to the clinician where there may be a risk of lung cancer according to the NICE guidelines. What ...

    • Cancer safety netting pathway.

      Introduction PCIT have developed a cancer safety netting pathway which provides practices with an end to end solution for managing fast track referrals, incorporating FIT testing requirements for colorectal cancer in keeping with IIF CAN02. This ...